| Literature DB >> 31409756 |
Xiuying Yang1,2, Daniel Brobst1, Wing Suen Chan3, Margaret Chui Ling Tse4, Oana Herlea-Pana1, Palak Ahuja3, Xinyi Bi3, Aung Moe Zaw3,5, Zara Sau Wa Kwong3, Wei-Hua Jia2, Zhong-Gou Zhang6, Ning Zhang7, Simon Kwoon Ho Chow7, Wing Hoi Cheung7, Jimmy Chun Yu Louie3, Timothy M Griffin1,8,9, Wenyan Nong10, Jerome Ho Lam Hui10, Guan-Hua Du2, Hye Lim Noh11, Suchaorn Saengnipanthkul11, Billy K C Chow3, Jason K Kim11, Chi Wai Lee12, Chi Bun Chan13,14.
Abstract
The ability of skeletal muscle to switch between lipid and glucose oxidation for ATP production during metabolic stress is pivotal for maintaining systemic energy homeostasis, and dysregulation of this metabolic flexibility is a dominant cause of several metabolic disorders. However, the molecular mechanism that governs fuel selection in muscle is not well understood. Here, we report that brain-derived neurotrophic factor (BDNF) is a fasting-induced myokine that controls metabolic reprograming through the AMPK/CREB/PGC-1α pathway in female mice. Female mice with a muscle-specific deficiency in BDNF (MBKO mice) were unable to switch the predominant fuel source from carbohydrates to fatty acids during fasting, which reduced ATP production in muscle. Fasting-induced muscle atrophy was also compromised in female MBKO mice, likely a result of autophagy inhibition. These mutant mice displayed myofiber necrosis, weaker muscle strength, reduced locomotion, and muscle-specific insulin resistance. Together, our results show that muscle-derived BDNF facilitates metabolic adaption during nutrient scarcity in a gender-specific manner and that insufficient BDNF production in skeletal muscle promotes the development of metabolic myopathies and insulin resistance.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31409756 PMCID: PMC7219567 DOI: 10.1126/scisignal.aau1468
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192